{"id":338620,"date":"2026-11-04T11:29:11","date_gmt":"2026-11-04T05:59:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-q2-results-fy27-pat-52-crore\/"},"modified":"2026-11-04T11:29:11","modified_gmt":"2026-11-04T05:59:11","slug":"neuland-laboratories-q2-results-fy27-pat-52-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-q2-results-fy27-pat-52-crore\/","title":{"rendered":"Neuland Laboratories Q2 Results FY27: Revenue Down 12.56% to Rs 449.66 Cr, PAT Down 46.69% to Rs 51.63 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Neuland Laboratories Q2 Results FY27 were declared on 3 November 2026 on a Consolidated basis. Revenue declined 12.56% YoY to Rs 449.66 Cr from Rs 514.27 Cr, and net profit fell 46.69% YoY to Rs 51.63 Cr from Rs 96.85 Cr. These quarterly results show lower YoY growth on every line, and the sections below cover the drivers, outlook and risks.<\/p>\n<\/div>\n

Neuland Laboratories Ltd (NEULANDLAB) Q2 Results FY27 announced on 3 November 2026, covering the consolidated financial performance for the July to September quarter. Neuland Laboratories Q2 Results FY27 put revenue at Rs 449.66 Cr, operating profit at Rs 97.56 Cr and PAT at Rs 51.63 Cr for the three months. The results date of 3 November 2026 is the base for each comparison below, and the YoY comparison uses the same quarter of last year.<\/p>\n

The results analysis for Neuland Laboratories Q2 Results covers the financial highlights, the business factors named in the data, the FY27 outlook and the risks to follow. Univest keeps its results notes figure first, so the highlights table below is the natural place to start.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n